Downregulation of the histone methyltransferase SETD2 promotes imatinib resistance in chronic myeloid leukaemia cells

Yaru Sheng , Zhongzhong Ji , Huifang Zhao , Jinming Wang , Chaping Cheng , Weimin Xu , Xue Wang (1) , Yuman He , Kaiyuan Liu , Li Li (2) , Thibault Voeltzel (3) , Veronique Maguer-Satta (3) , Wei‐qiang Gao , Helen He Zhu

1 Xjtu - Xi'an Jiaotong University
2 Institute of Atomic Physics
3 UNICANCER/CRCL - Centre de Recherche en Cancérologie de Lyon

Domaines: Sciences du Vivant [q-bio]; Biochimie, Biologie Moléculaire; Biologie moléculaire; Cancer; Médecine humaine et pathologie; Hématologie

Yaru Sheng, Zhongzhong Ji, Huifang Zhao, Jinming Wang, Chaping Cheng, et al.. Downregulation of the histone methyltransferase SETD2 promotes imatinib resistance in chronic myeloid leukaemia cells. Cell Proliferation, 2019, 52 (4), ⟨10.1111/cpr.12611⟩. ⟨hal-02363266⟩